Irene Becklund's departure as Chief Accounting Officer and Principal Accounting Officer of Hims & Hers Health, Inc. was reported, effective October 9, 2026; the filing names no successor (Form 8-K, July 17, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Hims & Hers Health, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · In / out: In · Person: Andrew Huberman · Role: Director · 8-K, 2026-11-09
- · In / out: Reported · Person: not named in the filing · 8-K, 2026-10-07
- · In / out: Out · Person: Irene Becklund · Role: Chief Accounting Officer and Principal Accounting Officer · Effective: 2026-10-09 · 8-K, 2026-07-17
Hims & Hers Health, Inc. reported changes in 3 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-07-17 to 2026-11-09. They name 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Hims & Hers Health, Inc. files it.
Also on the record for Hims & Hers Health, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 30, 2026 | Stake report, Schedule 13G/A, by Vanguard Capital Management | 4.97% of the class | 5%+ stakes | Source |
| August 31, 2026 | Stake report, Schedule 13D/A, by Andrew Dudum | 9.4% of the class | 5%+ stakes | Source |
| July 31, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 5.01% of the class | 5%+ stakes | Source |
| July 28, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 11.9% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G, by G1 Execution Services, LLC | 6.5% of the class | 5%+ stakes | Source |
| May 14, 2026 | Stake report, Schedule 13G/A, by Capital World Investors | — | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| March 5, 2026 | Stake report, Schedule 13G/A, by JPMORGAN CHASE & CO. | 1.7% of the class | 5%+ stakes | Source |
| February 13, 2026 | Stake report, Schedule 13G/A, by Capital World Investors | 6.5% of the class | 5%+ stakes | Source |
| October 31, 2025 | Stake report, Schedule 13G, by JPMORGAN CHASE & CO. | 8.1% of the class | 5%+ stakes | Source |
| August 13, 2025 | Stake report, Schedule 13D/A, by Andrew Dudum | 10.3% of the class | 5%+ stakes | Source |
| August 13, 2025 | Stake report, Schedule 13G, by Capital World Investors | 8.6% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Hims & Hers Health, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Hims & Hers Health, Inc. and the records around it.
Hims & Hers Health, Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
- Who owns it
Companies that share a holder
- G1 Execution Services, LLC also filed stake reports on 45 other companies: AmpliTech Group, Inc. (Aug 2026), Bitdeer Technologies Group (Aug 2026), Compass Diversified Holdings (Aug 2026)
- JPMORGAN CHASE & CO. also filed stake reports on 116 other companies: LEVI STRAUSS & CO (Nov 2026), Warner Music Group Corp. (Nov 2026), Andersen Group Inc. (Oct 2026)
- Capital World Investors also filed stake reports on 125 other companies: New Fortress Energy Inc. (Oct 2026), Aura Minerals Inc. (Oct 2026), Skyworks Solutions, Inc. (Oct 2026)
Watch Hims & Hers Health, Inc.
Get an email when Hims & Hers Health, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Hims & Hers Health, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Hims & Hers Health, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Hims & Hers Health, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
15 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-11-09 | In | Director | 8-K, 2026-11-09 | ||
| 2026-10-07 | Reported | not named in the filing | 8-K, 2026-10-07 | ||
| 2026-07-17 | Out | Chief Accounting Officer and Principal Accounting Officer | 2026-10-09 | 8-K, 2026-07-17 |
Who leads Hims & Hers Health, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Andrew Huberman, appointed (filed 2026-11-09).
- Chief Accounting Officer and Principal Accounting Officer: Irene Becklund, departure reported, effective 2026-10-09 (filed 2026-07-17). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Hims & Hers Health, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Hims & Hers Health, Inc., with the record behind each one.
Find candidates like Director at Hims & Hers Health, Inc.Every change, in the filing's words
Appointed: Andrew Huberman, Director
On November 4, 2026, the board of directors (the "Board") of Hims & Hers Health, Inc. (the "Company") increased the size of the Board from nine to ten directors and appointed Dr. Andrew Huberman, 51, to fill the newly created directorship, effective immediately.
- Dr. Huberman will serve until the Company's 2027 annual meeting of stockholders and until his successor is elected and qualified, or sooner in the event of his death, resignation or removal.
- The Board has determined that Dr. Huberman does not meet the requirements for independence under the applicable listing standards of the New York Stock Exchange.
- Dr. Huberman has not been appointed to any committee of the Board and is not currently expected to be appointed to any committee.
- Dr. Huberman will be entitled to receive compensation as outlined in the "Director Compensation" section in the Company's proxy statement filed with the Securities and Exchange Commission on April 28, 2026, except that Dr. Huberman's annual cash retainer will be $50,000, and his annual equity award will have a value of $250,000, prorated for his period of service from his appointment through the Company's 2027 annual meeting of stockholders, in each case in accordance with the Company's director compensation program, as amended from time to time.
Reported
Mr. Franklin's employment is at-will and may be terminated at any time by the Company or Mr. Franklin.
- On October 5, 2026, Jonathan M. Franklin commenced employment with Hims & Hers Health, Inc. (the "Company") as chief accounting officer.
- On October 7, 2026, the Company's board of directors appointed Mr. Franklin as principal accounting officer of the Company, effective October 9, 2026, concurrently with the previously disclosed resignation of Irene Becklund as the Company's principal accounting officer.
- As previously disclosed, the Company has entered into an advisory agreement with Ms. Becklund, effective October 10, 2026, pursuant to which she will continue to support the Company until July 10, 2027.
- Prior to joining the Company, Mr. Franklin, 43, served in several roles for Rivian Automotive, Inc., an electric vehicle manufacturer and automotive technology company, including as Vice President, Corporate Controller from April 2024 to October 2026, Vice President of Accounting from December 2023 to April 2024, and Senior Director of Corporate Accounting from March 2022 to December 2023.
- Before joining Rivian, Mr. Franklin held various roles with PwC, a professional services firm, beginning in 2006, most recently as an Assurance Director from June 2019 to March 2022.
- He is a certified public accountant in the state of Michigan.
- Mr. Franklin holds a Bachelor of Business Administration in Accounting and a Master of Accounting from the University of Michigan.
Departing: Irene Becklund, Chief Accounting Officer and Principal Accounting Officer, effective 2026-10-09
On July 13, 2026, Irene Becklund informed Hims & Hers Health, Inc. (the "Company") of her intention to resign as Chief Accounting Officer and Principal Accounting Officer, effective as of October 9, 2026.
- Ms. Becklund has indicated to the Company that her resignation is not the result of any dispute or disagreement with the Company's accounting principles or practices or financial statements and disclosures.
- Ms. Becklund has served as the Company's Chief Accounting Officer since April 2025 and the Company's Principal Accounting Officer since November 2021.
- The Company has entered into an advisory agreement with Ms. Becklund, effective as of October 10, 2026, pursuant to which Ms. Becklund will continue to support the Company until July 10, 2027.
Tools for this story
Each opens in a new tab, filled in for Hims & Hers Health, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.